Company Filing History:
1 out of 8 
1 out of 1 
1 out of 2 Years Active: 2022
Title: The Innovations of Bin Liu
Introduction
Bin Liu is a notable inventor based in Kaifeng, China. He has made significant contributions to the field of biotechnology, particularly in the development of blood-clotting factors. His work has implications for improving drug efficacy and patient outcomes in medical treatments.
Latest Patents
Bin Liu holds a patent for a highly glycosylated human blood-clotting factor VIII fusion protein, along with its manufacturing method and applications. This innovative fusion protein includes a human blood-clotting factor VIII, a flexible peptide connector, and a half-life extending portion, which enhances its pharmacokinetics and biological activity. The patent demonstrates Liu's commitment to advancing medical science and improving therapeutic options for patients.
Career Highlights
Throughout his career, Bin Liu has worked with prominent companies in the pharmaceutical industry. He has been associated with Ampsource Biopharma Shanghai Inc. and Furen Pharmaceutical Group Co., Ltd. His experience in these organizations has allowed him to contribute to significant advancements in biopharmaceuticals.
Collaborations
Bin Liu has collaborated with esteemed colleagues, including Qiang Li and Wenchen Zhu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.
Conclusion
Bin Liu's contributions to the field of biotechnology, particularly through his patent on a blood-clotting factor VIII fusion protein, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and improved patient care.